ABSTRACT
UNC93B1 is a transmembrane domain protein mediating the signaling of endosomal Toll-like receptors (TLRs). We report five families harboring rare missense substitutions (I317M, G325C, L330R, R466S, and R525P) in UNC93B1 causing systemic lupus erythematosus (SLE) or chilblain lupus (CBL) as either autosomal dominant or autosomal recessive traits. As for a D34A mutation causing murine lupus, we recorded a gain of TLR7 and, to a lesser extent, TLR8 activity with the I317M (in vitro) and G325C (in vitro and ex vivo) variants in the context of SLE. Contrastingly, in three families segregating CBL, the L330R, R466S, and R525P variants were isomorphic with respect to TLR7 activity in vitro and, for R525P, ex vivo. Rather, these variants demonstrated a gain of TLR8 activity. We observed enhanced interaction of the G325C, L330R, and R466S variants with TLR8, but not the R525P substitution, indicating different disease mechanisms. Overall, these observations suggest that UNC93B1 mutations cause monogenic SLE or CBL due to differentially enhanced TLR7 and TLR8 signaling.
Subject(s)
Chilblains , Lupus Erythematosus, Systemic , Toll-Like Receptor 7 , Humans , Lupus Erythematosus, Systemic/genetics , Toll-Like Receptor 7/genetics , Toll-Like Receptor 7/metabolism , Female , Male , Chilblains/genetics , Membrane Transport Proteins/genetics , Membrane Transport Proteins/metabolism , Gain of Function Mutation , Toll-Like Receptor 8/genetics , Toll-Like Receptor 8/metabolism , Pedigree , Mutation, Missense , HEK293 Cells , Lupus Erythematosus, Cutaneous/genetics , Lupus Erythematosus, Cutaneous/pathologyABSTRACT
In early 2020, the novel pathogenic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China, and rapidly propagated worldwide causing a global health emergency. SARS-CoV-2 binds to the angiotensin-converting enzyme 2 (ACE2) protein for cell entry, followed by proteolytic cleavage of the Spike (S) protein by the transmembrane serine protease 2 (TMPRSS2), allowing fusion of the viral and cellular membranes. Interestingly, TMPRSS2 is a key regulator in prostate cancer (PCa) progression which is regulated by androgen receptor (AR) signaling. Our hypothesis is that the AR signaling may regulate the expression of TMPRSS2 in human respiratory cells and thus influence the membrane fusion entry pathway of SARS-CoV-2. We show here that TMPRSS2 and AR are expressed in Calu-3 lung cells. In this cell line, TMPRSS2 expression is regulated by androgens. Finally, pre-treatment with anti-androgen drugs such as apalutamide significantly reduced SARS-CoV-2 entry and infection in Calu-3 lung cells but also in primary human nasal epithelial cells. Altogether, these data provide strong evidence to support the use of apalutamide as a treatment option for the PCa population vulnerable to severe COVID-19.
Subject(s)
COVID-19 , Male , Humans , COVID-19/metabolism , SARS-CoV-2/metabolism , Peptidyl-Dipeptidase A/metabolism , Lung/metabolism , Epithelial Cells/metabolism , Virus InternalizationABSTRACT
An efficient, solvent free method for the N-arylation of imidazole by 1-(dodecyloxy)-4-iodobenzene using Cu(II)-NaY as catalyst and K(2)CO(3) as base is reported. By this synthetic approach, mesomorphic 3-[4-(dodecyloxy)phenyl]-1-methyl-1H-imidazol-3-ium iodide was synthesized in a two-step procedure, and its mesomorphism has been fully investigated by polarised optical microscopy, differential scanning calorimetry and X-ray diffraction. In addition its lamellar crystal structure, electrochemical behaviour and UV (absorption and emission) properties are reported.
ABSTRACT
[reaction: see text] Upon tandem Reformatsky reaction, easily accessible porphyrinic ketones give "locked" chlorinic diester. Both ketones and diesters, as bases or palladium complexes, efficiently generate singlet dioxygen, as demonstrated by trapping with cholesterol.
